Clinically significant pleural effusion
ICD-10 J90; J91 · ICD-11 CB27

Parapneumonic Effusion or Pleural Infection Not Responding to Initial Chest Tube Drainage and Antibiotics

Clinical Scenario

This protocol addresses patients with parapneumonic effusion or suspected pleural infection who present with high-risk features: frank pus on diagnostic aspiration, or pleural fluid pH ≤7.2 — findings that indicate a complex parapneumonic effusion or established pleural infection requiring escalated management.

Previous Treatment — Goals Not Met

Escalation trigger

First-line management consists of small bore chest tube drainage with empirical antibiotic therapy adjusted by culture, including anaerobic cover. This step is expected to yield good clinical progress within 48 hours: a resolving pleural collection on imaging and reducing inflammatory markers. When that response is absent at 48 hours, escalation to the next evidence-based step is indicated.

Next-Step Approach

When initial chest tube drainage has ceased but a residual pleural collection remains, intrapleural combination therapy is a key evidence-based option — with further pathways available depending on clinical suitability. Full regimen details, decision criteria, and dosing are in the structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1136/thorax-2023-220304

For patients with parapneumonic effusion (PPE) or suspected pleural infection, where diagnostic aspiration does not yield frank pus, immediate pH analysis should be performed.

If pleural fluid pH ≤7.2 this implies a high risk of CPPE or pleural infection and an intercostal drain (ICD) should be inserted if the volume of accessible pleural fluid on ultrasound makes it safe to do so.

Combination tissue plasminogen activator (TPA) and DNAse should be considered for the treatment of pleural infection, where initial chest tube drainage has ceased and leaves a residual pleural collection.

View source ↗